Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial. Issue 4 (27th December 2021) - Han, Eugene; Huh, Ji Hye; Lee, Eun Y.; Bae, Ji C.; Chun, Sung W.; Yu, Sung H.; Kwak, Soo H.; Park, Kyong S.; Lee, Byung‐Wan